Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges
Authors
Keywords
-
Journal
Science Advances
Volume 8, Issue 4, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-01-27
DOI
10.1126/sciadv.abi8618
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The distribution of cellular turnover in the human body
- (2021) Ron Sender et al. NATURE MEDICINE
- Analysis of recurrently protected genomic regions in cell-free DNA found in urine
- (2021) Havell Markus et al. Science Translational Medicine
- Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
- (2021) Justin M. Burgener et al. CLINICAL CANCER RESEARCH
- HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA
- (2021) Eric Leung et al. CLINICAL CANCER RESEARCH
- Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
- (2020) Aparna R. Parikh et al. CLINICAL CANCER RESEARCH
- Plasmatic KRAS Kinetics for the Prediction of Treatment Response and Progression in Patients With KRAS-mutant Lung Adenocarcinoma
- (2020) Álvaro Taus et al. ARCHIVOS DE BRONCONEUMOLOGIA
- The effect of surgical trauma on circulating free DNA levels in cancer patients – implications for studies of circulating tumor DNA
- (2020) Tenna V. Henriksen et al. Molecular Oncology
- Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
- (2020) Asaf Zviran et al. NATURE MEDICINE
- Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients – initial observations
- (2020) Lotte Nygård et al. PLoS One
- Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer
- (2020) Jian Yang et al. Cell Death & Disease
- Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort
- (2020) Yong Song et al. Translational Lung Cancer Research
- Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
- (2020) M.C. Liu et al. ANNALS OF ONCOLOGY
- Emerging Precision Oncology Applications of Liquid Biopsy using Circulating Tumour DNA and Methylome Profiling
- (2020) E.Y. Zhao et al. CLINICAL ONCOLOGY
- Senescence, Necrosis, and Apoptosis Govern Circulating Cell-free DNA Release Kinetics
- (2020) Ariana Rostami et al. Cell Reports
- Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer
- (2020) Jiahong Jiang et al. Frontiers in Oncology
- Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition
- (2020) Barzin Y. Nabet et al. CELL
- Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies
- (2020) Jeanne Tie et al. INTERNATIONAL JOURNAL OF CANCER
- Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA
- (2020) Manouk K. Bos et al. Molecular Oncology
- Prognostic and predictive impact of circulating tumor DNA in patients with advanced cancers treated with immune checkpoint blockade
- (2020) Qu Zhang et al. Cancer Discovery
- Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy
- (2020) Sik-Kwan Chan et al. Frontiers in Oncology
- A mathematical model of ctDNA shedding predicts tumor detection size
- (2020) Stefano Avanzini et al. Science Advances
- Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival
- (2020) M.J.M. Magbanua et al. ANNALS OF ONCOLOGY
- Novel patterns of response under immunotherapy
- (2019) E Borcoman et al. ANNALS OF ONCOLOGY
- Low-Pass Whole-Genome Sequencing of Circulating Cell-Free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort
- (2019) Xiaoji Chen et al. CLINICAL CANCER RESEARCH
- Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA
- (2019) L Tan et al. ANNALS OF ONCOLOGY
- Early ctDNA dynamics as a surrogate for progression free survival in advanced breast cancer in the BEECH trial
- (2019) S Hrebien et al. ANNALS OF ONCOLOGY
- Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer
- (2019) B Lee et al. ANNALS OF ONCOLOGY
- Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma
- (2019) Zhixiong Cai et al. CLINICAL CANCER RESEARCH
- Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS ‐mutant metastatic colorectal cancer
- (2019) Elena Elez et al. Molecular Oncology
- Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study
- (2019) Andrea Forschner et al. Journal for ImmunoTherapy of Cancer
- Perioperative dynamic changes in circulating tumor DNA in lung cancer patients (DYNAMIC)
- (2019) Kezhong Chen et al. CLINICAL CANCER RESEARCH
- Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer
- (2019) Emilie Moati et al. INTERNATIONAL JOURNAL OF CANCER
- Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
- (2019) Bradon R. McDonald et al. Science Translational Medicine
- Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
- (2019) N Tarazona et al. ANNALS OF ONCOLOGY
- Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer
- (2019) Nicolas Guibert et al. LUNG CANCER
- High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
- (2019) Pedram Razavi et al. NATURE MEDICINE
- Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinoma
- (2019) Jiawei Lv et al. Nature Communications
- Early change in circulating tumor DNA as a potential predictor of response to chemotherapy in patients with metastatic colorectal cancer
- (2019) Hiroki Osumi et al. Scientific Reports
- Day-to-day and within-day biological variation of cell-free DNA
- (2019) Anne Tranberg Madsen et al. EBioMedicine
- Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
- (2018) Sarah B. Goldberg et al. CLINICAL CANCER RESEARCH
- Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR -Mutant Lung Adenocarcinoma
- (2018) Álvaro Taus et al. Clinical Lung Cancer
- Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse
- (2018) Karinna Almodovar et al. Journal of Thoracic Oncology
- Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
- (2018) Seung Tae Kim et al. NATURE MEDICINE
- MutantKRASCirculating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring
- (2018) Ruth Perets et al. ONCOLOGIST
- Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer
- (2018) Ben O’Leary et al. Nature Communications
- Dynamic changes in plasma Epstein-Barr virus DNA load during treatment have prognostic value in nasopharyngeal carcinoma: a retrospective study
- (2018) Sha-Sha He et al. Cancer Medicine
- Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti–Programmed Cell Death 1 Antibodies
- (2018) Jenny H. Lee et al. JAMA Oncology
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
- (2018) David M. Kurtz et al. JOURNAL OF CLINICAL ONCOLOGY
- The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis
- (2018) Francesco Passiglia et al. Scientific Reports
- Dynamics of tumor and immune responses during immune checkpoint blockade in non-small cell lung cancer
- (2018) Valsamo Anagnostou et al. CANCER RESEARCH
- Monitoring Tumor Burden in Response to FOLFIRINOX Chemotherapy Via Profiling Circulating Cell-Free DNA in Pancreatic Cancer
- (2018) Tao Wei et al. MOLECULAR CANCER THERAPEUTICS
- Sensitive tumour detection and classification using plasma cell-free DNA methylomes
- (2018) Shu Yi Shen et al. NATURE
- Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease
- (2018) Joshua Moss et al. Nature Communications
- HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report
- (2017) Luc Cabel et al. INTERNATIONAL JOURNAL OF CANCER
- Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study
- (2017) Kala Visvanathan et al. JOURNAL OF CLINICAL ONCOLOGY
- Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
- (2017) Alexander W Wyatt et al. JNCI-Journal of the National Cancer Institute
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- (2017) Christopher Abbosh et al. NATURE
- DNA sequencing technologies: 2006–2016
- (2017) Elaine R Mardis Nature Protocols
- Dynamic tracing for epidermal growth factor receptor mutations in urinary circulating DNA in gastric cancer patients
- (2017) Xiu-Qin Shi et al. TUMOR BIOLOGY
- Monitoring of KRAS-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinoma
- (2017) Nicolas Guibert et al. Oncotarget
- Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
- (2017) Alexander W Wyatt et al. JNCI-Journal of the National Cancer Institute
- Cell-Free DNA Kinetics in a Pre-Clinical Model of Head and Neck Cancer
- (2017) Nidal Muhanna et al. Scientific Reports
- Dynamics of circulating tumor DNA represented by the activating and resistant mutations in epidermal growth factor receptor tyrosine kinase inhibitor treatment
- (2016) Junji Uchida et al. CANCER SCIENCE
- Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma
- (2016) Liqiang Xi et al. CLINICAL CANCER RESEARCH
- Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker
- (2016) Daniel Pietrasz et al. CLINICAL CANCER RESEARCH
- Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma
- (2016) M. Krumbholz et al. CLINICAL CANCER RESEARCH
- Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial
- (2016) Qing Zhou et al. Journal of Hematology & Oncology
- Applications for quantitative measurement of BRAF V600 mutant cell-free tumor DNA in the plasma of patients with metastatic melanoma
- (2016) Max Schreuer et al. MELANOMA RESEARCH
- Integrated digital error suppression for improved detection of circulating tumor DNA
- (2016) Aaron M Newman et al. NATURE BIOTECHNOLOGY
- Variations in EGFR ctDNA Correlates to the Clinical Efficacy of Afatinib in Non Small Cell Lung Cancer with Acquired Resistance
- (2016) Jinfeng He et al. PATHOLOGY & ONCOLOGY RESEARCH
- Identification of tissue-specific cell death using methylation patterns of circulating DNA
- (2016) Roni Lehmann-Werman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
- (2016) Jeanne Tie et al. Science Translational Medicine
- Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients
- (2016) Anja Lisa Riediger et al. Scientific Reports
- Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
- (2016) Christine A. Parkinson et al. PLOS MEDICINE
- Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patients
- (2016) Kikuya Kato et al. Scientific Reports
- Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
- (2015) J. Tie et al. ANNALS OF ONCOLOGY
- Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
- (2015) Eleonor Olsson et al. EMBO Molecular Medicine
- Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
- (2015) Thomas Reinert et al. GUT
- Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
- (2015) Kun Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
- (2015) Isaac Garcia-Murillas et al. Science Translational Medicine
- Plasma Epstein–Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma
- (2014) S. F. Leung et al. ANNALS OF ONCOLOGY
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
- (2014) Aaron M Newman et al. NATURE MEDICINE
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- The correlation between cell-free DNA and tumour burden was estimated by PET/CT in patients with advanced NSCLC
- (2013) A D Nygaard et al. BRITISH JOURNAL OF CANCER
- High-Resolution Profiling of Fetal DNA Clearance from Maternal Plasma by Massively Parallel Sequencing
- (2013) S. C. Y. Yu et al. CLINICAL CHEMISTRY
- Quantification of circulating Epstein–Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance
- (2013) Y-L Kwong et al. LEUKEMIA
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantitative analysis of free-circulating DNA in plasma of patients with resectable NSCLC
- (2012) Adam Szpechcinski et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma
- (2011) Kimberley Jones et al. AMERICAN JOURNAL OF HEMATOLOGY
- Cell-free plasma DNA and purine nucleotide degradation markers following weightlifting exercise
- (2010) Johanna Atamaniuk et al. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now